PROCESS FOR EXTRACTING AND RECOVERING TANTALUM PRESENT IN AN ACID AQUEOUS PHASE BY MEANS OF AN IONIC LIQUID, AND USE OF SUCH AN IONIC LIQUID FOR EXTRACTING THE TANTALUM FROM AN ACID AQUEOUS PHASE
20180230572 ยท 2018-08-16
Inventors
- Raphael Turgis (Sabran, FR)
- Guilhem Arrachart (Saint Laurent des Arbres, FR)
- St?phane PELLET-ROSTAING (Villeurbanne, FR)
- Micheline Draye (Chambery, FR)
- Sophie Legeai (Metz, FR)
- David Virieux (Montpellier, FR)
- Christian Thomas (Paris, FR)
Cpc classification
Y02P10/20
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
C01G35/003
CHEMISTRY; METALLURGY
C25C1/06
CHEMISTRY; METALLURGY
C22B3/26
CHEMISTRY; METALLURGY
International classification
C22B3/26
CHEMISTRY; METALLURGY
C25C1/06
CHEMISTRY; METALLURGY
Abstract
A method for extracting the tantalum from an acid aqueous phase A1 comprising at least one step comprising the bringing of the aqueous phase A1 into contact with a phase A2 not miscible with water, and then the separation of the aqueous phase A1 from the phase A2, the phase A2 consisting of one ionic liquid or a mixture of ionic liquids as an extractant. A method for recovering the tantalum that implements this extraction method and to a use of an ionic liquid or of a mixture of ionic liquids as an extractant, in order to extract the tantalum from such an aqueous phase A1.
Claims
1. Method for extracting the tantalum from an acid aqueous phase A1 comprising at least one step comprising the bringing of the aqueous phase A1 into contact with a phase A2 that is not miscible with water, and then the separation of the aqueous phase A1 from the phase A2, characterised in that the phase A2 consists of one ionic liquid or a mixture of ionic liquids as an extractant.
2. Extraction method according to claim 1, wherein the phase A2 consists of one ionic liquid.
3. Extraction method according to claim 1, wherein the ionic liquid or the ionic liquids comprise an organic cation and an anion, said organic cation comprises a nitrogen group chosen from the group consisting of a quaternary ammonium, which is cyclical or non-cyclical, a phosphonium, a piperidinium, a pyridinium, a pyrrolidinium, a piperazinium and an imidazolium.
4. Extraction method according to claim 3, wherein the organic cation is chosen from the group consisting of a piperidinium, a pyridinium, a pyrrolidinium, a piperazinium and an imidazolium.
5. Extraction method according to claim 4, wherein the organic cation is chosen from the group consisting of a dialkylpiperidinium, an alkylpyridinium, an N,N-dialkylpiperazinium and an N,N-dialkylimidazolium.
6. Extraction method according to claim 3, wherein the organic cation further comprises at least one functional group chosen from a ketone, an alcohol, a phosphonate and a phosphine oxide.
7. Extraction method according to claim 6, wherein the functional group is a phosphonate.
8. Extraction method according to claim 3, wherein the anion is chosen from bis-(trifluoromethanesulfonyl)imide, hexafluorophosphate and bis-(fluorosulfonyl)imide and is advantageously bis-(trifluoromethanesulfonyl)imide.
9. Extraction method according to claim 8, wherein the ionic liquid is chosen from: N-ethyl-N-(4-methyl-2-oxopentyl)-piperidinium bis-(trifluoromethanesulfonyl)imide, N-methyl-N-(4-methyl-2-oxopentyl)imidazolium bis-(trifluoromethanesulfonyl)imide, N-(4-methyl-2-oxopentyl)pyridinium bis-(trifluoromethanesulfonyl)imide, (4-(dibutoxyphosphoryl)-butyl)ethylpiperidinium bis-(trifluoromethanesulfonyl)imide, ethylbutylpiperidinium bis-(trifluoromethanesulfonyl)imide, and methylimidazolium bis-(trifluoromethanesulfonyl)imide.
10. Extraction method according to claim 1, carried out at ambient temperature.
11. Method for recovering the tantalum present in an acid aqueous phase A1, characterised in that it comprises: (a) the extraction of the tantalum from the aqueous phase A1 by an extraction method according to claim 1; and (b) the stripping of said tantalum present in the phase A2 as obtained after step (a), or (b) the electrodeposition of said tantalum present in the phase A2 as obtained after step (a).
12. Recovery method according to claim 11, wherein the step (b) of stripping comprises the bringing of this phase A2 into contact with an aqueous phase A3 having a pH that is less than or equal to 7, and then the separation of the phase A2 from the aqueous phase A3.
13. Recovery method according to claim 11, wherein the step (b) of electrodeposition involves applying a difference in potential between a cathode and a reference electrode, in the presence of a working electrode, all of these electrodes being placed in this phase A2, between ?0.8 V and ?2.4 V.
14. Extraction method according to claim 1, wherein the aqueous phase A1 is an acid digestion solution of a concentrate of a natural or urban ore comprising said tantalum.
15. Extraction method according to claim 14, wherein the aqueous phase A1 comprises at least one inorganic acid chosen from the group consisting of hydrofluoric acid, sulphuric acid, nitric acid, phosphoric acid and hydrochloric acid.
16. Extraction method according to claim 15, wherein the aqueous phase A1 has a total molar concentration of inorganic acid(s) of at least 0.1 mol/L, advantageously from 1 mol/L to 14 mol/L and, preferably, from 3 mol/L to 9 mol/L.
17. Use of one ionic liquid or of a mixture of ionic liquids as an extractant, in order to extract the tantalum from an acid aqueous phase A1, said ionic liquid(s) comprising an organic cation and an anion, said organic cation comprising a nitrogen group chosen from the group consisting of a piperidinium, a pyridinium, a pyrrolidinium, a piperazinium and an imidazolium.
18. Use according to claim 17, wherein the organic cation is chosen from the group consisting of a dialkylpiperidinium, an alkylpyridinium, an N,N-dialkylpiperazinium and an N,N-dialkylimidazolium.
19. Use according to claim 17, wherein the organic cation further comprises at least one functional group chosen from a ketone, an alcohol, a phosphonate and a phosphine oxide.
20. Use according to claim 17, wherein the anion is bis-(trifluoromethanesulfonyl)imide.
21. Use according to claim 17, wherein the extraction is carried out via the technique of liquid-liquid extraction.
22. Recovery method according to claim 11, wherein the aqueous phase A1 is an acid digestion solution of a concentrate of a natural or urban ore comprising said tantalum.
23. Recovery method according to claim 22, wherein the aqueous phase A1 comprises at least one inorganic acid chosen from the group consisting of hydrofluoric acid, sulphuric acid, nitric acid, phosphoric acid and hydrochloric acid.
24. Recovery method according to claim 23, wherein the aqueous phase A1 has a total molar concentration of inorganic acid(s) of at least 0.1 mol/L, advantageously from 1 mol/L to 14 mol/L and, preferably, from 3 mol/L to 9 mol/L.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0110]
[0111]
[0112]
[0113]
[0114]
[0115]
[0116]
[0117]
[0118]
[0119]
[0120]
[0121]
[0122]
[0123]
[0124]
EXAMPLES
Synthesis of Ionic Liquids
Example 1: Synthesis of Ionic Liquids Comprising a Ketone Function
[0125] As indicated above, the synthesis of ionic liquids comprising a ketone function can be carried out according to the pathway A or the pathway B. Regardless of the pathway A or B used, this synthesis requires those of intermediate compounds, noted hereinafter as Compounds I, comprising a halide anion.
1.1 Synthesis of the Intermediate Compounds
1.1.1 According to the Pathway A
[0126] The reactions used are the following:
##STR00022##
[0127] A.1 Synthesis of ?-Brominated Ketones
[0128] The operating protocol followed for the synthesis of ?-brominated ketones is the following: 100 mmol of N-bromosuccinimide are added all at once to a solution of 100 mmol of ketone CH.sub.3C(O)R.sub.1 and of 10 mmol of p-toluenesulfonic acid in 100 mL of ethyl acetate. The mixture is stirred for 4 h at ambient temperature and away from light. The mixture is then filtered, the organic phase washed with a 1M solution of potassium carbonate, of saturated sodium thiosulfate and with distilled water (2 times). The organic phase is then dried over sodium sulphate and concentrated under vacuum. The ?-brominated ketone obtained is in the form of a yellow oil.
[0129] The ?-brominated ketones C1 to C3, which were synthesised in accordance with the operating protocol described just above, are specified in Table 1 below.
TABLE-US-00001 TABLE 1 ?- brominated Yield ketone R.sub.1 ?-brominated ketone obtained (%) C1 (CH.sub.3).sub.2CHCH.sub.2 1-bromo-4-methyl-pentan-2-one (*) 61 C2 C.sub.6H.sub.5 2-bromo-acetophenone 95 C3 p-CH.sub.3C.sub.6H.sub.4 2-bromo-4-methyl-acetophenone 95
[0130] The asterisk noted as (*) in Table 1 specifies that the 1-bromo-4-methyl-pentan-2-one (ketone C1) is obtained in a mixture with 3-bromo-4-methyl-pentan-2-one, with a ratio of 65/35.
[0131] The characterisation data for these ?-brominated ketones C1 to C3 are the following:
Ketone C1: 1-bromo-4-methyl-pentan-2-one
[0132] .sup.1H NMR (400 MHz, CDCl.sub.3) ? (ppm): 0.92 (d, 6H, J=6.7 Hz, CH.sub.3); 2.18 (m, 1H, CH); 2.51 (d, 2H, J=7.0 Hz, C(O)CH.sub.2); 3.86 (s, 2H, BrCH.sub.2C(O))
Ketone C2: 2-bromo-acetophenone
[0133] .sup.1H NMR (400 MHz, CDCl.sub.3) ? (ppm): 4.56 (s, 2H, BrCH.sub.2C(O)); 7.49 (t, 2H, J=7.5 Hz, CH.sub.Ar); 7.61 (t, 2H, J=7.5 Hz, CH.sub.Ar); 7.98 (d, 2H, J=7.5 Hz, CH.sub.Ar).
Ketone C3: 2-bromo-4-methylacetophenone
[0134] .sup.1H NMR (400 MHz, CDCl.sub.3) ? (ppm): 2.42 (s, 3H, CH.sub.3); 4.43 (s, 2H, BrCH.sub.2C(O)); 7.29 (d, 2H, J=8.0 Hz, CH.sub.Ar); 7.88 (d, 2H, J=8.0 Hz, CH.sub.Ar).
A.2 Synthesis of Compounds I
[0135] The operating protocol followed for the synthesis of Compounds I is described in reference to the synthesis of N-ethyl-N-(4-methyl-2-oxopentyl)piperidinium bromide, noted as [EPipMIBK]Br, from the mixture of 1-bromo-4-methyl-pentan-2-one (?-brominated ketone C1) and 3-bromo-4-methyl-pentan-2-one synthesised in chapter A.1 above.
[0136] 17 mL (126 mmol) of ethylpiperidine are added drop by drop to a solution of 1-bromo-4-methyl-pentan-2-one and of 3-bromo-4-methyl-pentan-2-one in a ratio of 65/35 (31.45 g of mixture or 18.87 g corresponding to 105 mmol of ?-brominated ketone C1) in 100 mL of ethyl acetate. The mixture is stirred at ambient temperature for 12 h. The heterogeneous mixture is then filtered, the salts are washed 2 times with ethyl acetate and then the solvent is evaporated at a reduced pressure. The compound [EPipMIBK]Br obtained, noted as I1, is in the form of a white solid (23.0 g, i.e. a yield of 75%).
[0137] The Compounds I1 to I5 (synthesised in accordance with the operating protocol described just above), as well as the Compounds I6 and I7 (the synthesis of which is detailed below), are specified in Table 2 below.
TABLE-US-00002 TABLE 2 Abbreviation Compounds ?-halogenated Nitrogen of the Yield I ketone compound Compound 1 (%) I1 C1 ethylpiperidine [EPipMIBK]Br 75 I2 C2 ethylpiperidine [EPipAcP]Br 95 I3 C3 ethylpiperidine [EPipAcMP]Br 88 I4 C1 methylimidazole [MIMMIBK]Br 80 I5 C1 pyridine [PyMIBK]Br 80 I6 1- ethylpiperidine [EPipPin]I 80 iodopinacolone I7 1- methylimidazole [MIMPin]Cl 80 chloropinacolone
[0138] The semi-structural formulas and characterisation data of these Compounds I1 to I7 are the following:
Compound I1: N-ethyl-N-(4-methyl-2-oxopentyl)piperidinium bromide, [EPipMIBK]Br, Having the Formula
[0139] ##STR00023##
[0140] .sup.1H NMR (400 MHz, CDCl.sub.3) ? (ppm): 0.76 (d, 3H, J=6.5 Hz, CH.sub.3); 1.18 (t, 3H, J=7.5 Hz, CH.sub.3CH.sub.2N); 1.61-1.86 (m, 6H, CH.sub.2); 2.01 (m, 1H, CH); 2.39 (d, 2H, J=7.0 Hz, C(O)CH.sub.2); 3.54 (m, 2H, CH.sub.2N); 3.71 (q, 2H, J=7.5 Hz, CH.sub.3CH.sub.2N); 3.88 (m, 2H, CH.sub.2N); 4.86 (s, 2H, NCH.sub.2C(O)).
[0141] .sup.13C NMR (100 MHz, CDCl.sub.3) ? (ppm): 8.2 (CH.sub.3); 19.7; 20.6 (CH.sub.2); 22.3 (CH.sub.3); 24.0 (CH); 49.9 (C(O)CH.sub.2); 53.8 (CH.sub.3CH.sub.2N); 59.2 (CH.sub.2N); 63.1 (NCH.sub.2C(O)); 202.3 (C(O)).
Compound I2: N-ethyl-N-acetophenone piperidinium bromide, [EPipAcP]Br, Having the Formula
[0142] ##STR00024##
[0143] .sup.1H NMR (400 MHz, CDCl.sub.3) ? (ppm): 1.31 (t, 3H, J=7.5 Hz, CH.sub.3CH.sub.2N); 1.79 (m, 2H, CH.sub.2); 1.91 (m, 4H, CH.sub.2); 3.83 (dt, 2H, J=12.5 Hz, J=4.5 Hz, m, CH.sub.2CH.sub.2N); 3.94 (m, 2H, J=7.5 Hz, CH.sub.3CH.sub.2N); 4.38 (m, 2H, CH.sub.2N); 5.62 (s, 2H, NCH.sub.2C(O)); 7.44 (t, 2H, J=7.5 Hz, CH.sub.Ar); 7.57 (t, 1H, J=7.5 Hz, CH.sub.Ar); 8.19 (d, 2H, J=7.5 Hz, CH.sub.Ar).
[0144] .sup.13C NMR (100 MHz, CDCl.sub.3) ? (ppm): 8.4 (CH.sub.3); 20.1; 20.7 (CH.sub.2); 53.2 (CH.sub.3CH.sub.2N); 59.7 (CH.sub.2N); 61.6 (NCH.sub.2C(O)); 128.8; 129.1 (CH.sub.Ar); 134.1 (C.sub.Ar); 135.0 (CH.sub.Ar); 191.5 (C(O)).
Compound I3: N-ethyl-N-4-methylacetophenone piperidinium bromide, [EPipMAcP]Br, Having the Formula
[0145] ##STR00025##
[0146] .sup.1H NMR (400 MHz, CDCl.sub.3) ? (ppm): 1.30 (t, 3H, J=7.5 Hz, CH.sub.3CH.sub.2N); 1.79-1.91 (m, 6H, CH.sub.2); 2.34 (s, 3H, CH.sub.3Ar); 3.81 (dt, 2H, J=12.5 Hz, J=4.5 Hz, m, CH.sub.2CH.sub.2N); 3.93 (m, 2H, J=7.5 Hz, CH.sub.3CH.sub.2N); 4.38 (m, 2H, CH.sub.2N); 5.55 (s, 2H, NCH.sub.2C(O)); 7.23 (d, 2H, J=8.0 Hz, CH.sub.Ar); 8.07 (d, 2H, J=8.0 Hz, CH.sub.Ar).
[0147] .sup.13C NMR (100 MHz, CDCl.sub.3) ? (ppm): 8.4 (CH.sub.3); 20.1; 20.7 (CH.sub.2); 21.8 (CH.sub.3Ar); 53.2 (CH.sub.3CH.sub.2N); 59.7 (CH.sub.2N); 61.4 (NCH.sub.2C(O)); 128.9; 129.8 (CH.sub.Ar); 131.6 (C.sub.Ar); 146.2 (CH.sub.Ar); 190.9 (C(O)).
Compound I4: N-methyl-N-(4-methyl-2-oxopentyl)imidazolium bromide, [MIMMIBK]Br, Having the Formula
[0148] ##STR00026##
[0149] .sup.1H NMR (400 MHz, CDCl.sub.3) ? (ppm): 0.91 (d, 3H, J=6.5 Hz, CH.sub.3); 2.15 (m, 1H, CH); 2.53 (d, 2H, J=7.0 Hz, C(O)CH.sub.2); 4.02 (s, 3H, CH.sub.3N); 5.67 (s, 2H, NCH.sub.2C(O)); 7.47 (q, 1H, J=2.0 Hz, CH.sub.Ar); 7.61 (q, 1H, J=2.0 Hz, CH.sub.Ar); 9.78 (S, 1H, J=2.0 Hz, CH.sub.Ar).
[0150] .sup.13C NMR (100 MHz, CDCl.sub.3) ? (ppm): 22.6 (CH.sub.3); 24.2 (CH); 36.9 (CH.sub.3Ar); 48.9 (C(O)CH.sub.2); 60.0 (NCH.sub.2C(O)); 122.7 (CH.sub.Ar); 124.1 (CH.sub.Ar); 137.9 (CH.sub.Ar); 201.7 (C(O)).
Compound I5: N-(4-methyl-2-oxopentyl)pyridinium bromide, [PyMIBK]Br, Having the Formula
[0151] ##STR00027##
[0152] .sup.1H NMR (400 MHz, CDCl.sub.3) ? (ppm): 0.91 (d, 3H, J=6.5 Hz, CH.sub.3); 2.19 (m, 1H, CH); 2.57 (d, 2H, J=7.0 Hz, C(O)CH.sub.2); 6.51 (s, 2H, NCH.sub.2C(O)); 8.04 (t, 2H, J=7.0 Hz, CH.sub.Ar); 8.49 (q, 1H, J=7.0 Hz, CH.sub.Ar); 9.31 (d, 2H, J=6.0 Hz, CH.sub.Ar).
[0153] .sup.13C NMR (100 MHz, CDCl.sub.3) ? (ppm): 22.7 (CH.sub.3); 24.1 (CH); 49.0 (C(O)CH.sub.2); 66.6 (NCH.sub.2C(O)); 127.6 (CH.sub.Ar); 145.5 (CH.sub.Ar); 146.3 (CH.sub.Ar); 200.3 (C(O)).
Compound I6: N-ethyl-N-pinacolone piperidinium iodide, [EPipPin]I, Having the Formula
[0154] ##STR00028##
[0155] The operating protocol implemented in order to synthesise the Compound I6 is the following: 24 mmol of ethylpiperidine are added to a solution of 20 mmol of 1-iodopinacolone in 20 mL of ethyl acetate and the mixture is stirred at 50? C. for 12 h. The heterogeneous mixture obtained is then filtered, the salts are washed 2 times with ethyl acetate and then the solvent is evaporated at a reduced pressure. The compound [EPipPin]I, which is obtained with a yield of 80%, is in the form of a very hygroscopic white solid.
[0156] The characterisation data of this compound are the following:
[0157] .sup.1H NMR (400 MHz, CDCl.sub.3) ? (ppm): 1.26 (s, 9H, CH.sub.3); 1.31 (t, 3H, J=7.5 Hz, CH.sub.3CH.sub.2N); 1.74-1.98 (m, 6H, CH.sub.2); 3.73-3.84 (m, 4H, CH.sub.2N; CH.sub.3CH.sub.2N); 4.20 (m, 2H, CH.sub.2N); 5.07 (s, 2H, NCH.sub.2C(O)).
[0158] .sup.13C NMR (100 MHz, CDCl.sub.3) ? (ppm): 8.6 (CH.sub.3CH.sub.2N); 20.0; 20.5 (CH.sub.2); 26.6 (CH.sub.3); 45.0 (C(O)C(CH.sub.3).sub.3); 52.5 (CH.sub.3CH.sub.2N); 59.6 (CH.sub.2N; NCH.sub.2C(O)); 208.1 (C(O)).
Compound I7: N-pinacolone methylimidazolium chloride, [MIMPin]Cl, Having the Formula
[0159] ##STR00029##
[0160] The operating protocol implemented in order to synthesise the Compound I7 is the following: 24 mmol of methylimidazole are added to a solution of 20 mmol of 1-chloropinacolone in 20 mL ethyl acetate and the mixture is stirred at ambient temperature for 12 h. The heterogeneous mixture obtained is then filtered, the salts are washed 2 times with ethyl acetate and then the solvent is evaporated at a reduced pressure. The compound [MIMPin]Cl, which is obtained with a yield of 80%, is in the form of a very hygroscopic white solid.
[0161] The characterisation data of this compound are the following:
[0162] .sup.1H NMR (400 MHz, CDCl.sub.3) ? (ppm): 1.20 (s, 9H, CH.sub.3); 3.96 (s, 3H, CH.sub.3Ar); 5.84 (s, 2H, NCH.sub.2C(O)); 7.49 (s, 1H, CH.sub.Ar); 7.62 (s, 1H, CH.sub.Ar); 10.07 (s, 1H, CH.sub.Ar).
[0163] .sup.13C NMR (100 MHz, CDCl.sub.3) ? (ppm): 26.2 (CH.sub.3); 36.6 (CH.sub.3N); 43.4 ((CH.sub.3).sub.3CC(O)); 54.3 (C(O)CH.sub.2); 122.5 (CH.sub.Ar); 124.2 (CH.sub.Ar); 138.4 (CH.sub.Ar); 206.8 (C(O)).
1.1.2 According to the Pathway B
[0164] The reactions implemented are the following:
##STR00030##
B.1 Synthesis of the 5-bromopentan-2-one
[0165] 13.5 mL (117 mmol) of hydrobromic acid at 48% are added to a solution of 10 g (78 mmol) of acetylbutyrolactone in the toluene. The mixture is heated to 80? C. overnight. After cooling, the biphasic mixture is separated. The aqueous phase is extracted two times with diethyl ether. The organic phases are then brought together, washed two times with water, dried over magnesium sulphate and concentrated. After distillation at a reduced pressure (100? C. at 20 mmbar), the 5-bromopentan-2-one (12.7 g, i.e. a yield of 80%) that is in the form of a colourless oil is obtained.
[0166] The characterisation data of this compound are the following:
[0167] .sup.1H NMR (400 MHz, CDCl.sub.3) ? (ppm): 2.11 (m, 2H, (O)CCH.sub.2CH.sub.2CH.sub.2Br); 2.16 (s, 3H, CH.sub.3(O)C); 2.63 (t, J=7.0 Hz, 2H, (O)CCH.sub.2CH.sub.2CH.sub.2Br); 3.44 (t, J=6.5 Hz, 2H, (O)CCH.sub.2CH.sub.2CH.sub.2Br).
B.2 Synthesis of 5-(piperidinyl)pentan-2-one
[0168] 6.0 g (43 mmol) of potassium carbonate and then a solution formed by 3.56 g (21.6 mmol) of 5-bromopentan-2-one synthesised in paragraph B.1 in 10 mL of dry acetonitrile are added successively and under an inert atmosphere to a solution of 2.4 mL (23.7 mmol) of piperidine in 30 mL of dry acetonitrile. The mixture is then heated to 80? C. for 2 h. After cooling, the mixture is filtered, the salts are washed with acetonitrile. The mixture is then concentrated under vacuum. The 5-(piperidinyl)pentan-2-one (3.53 g, i.e. a yield of 97%) thus obtained is in the form of a slightly yellow oil.
[0169] The characterisation data of this compound are the following:
[0170] .sup.1H NMR (400 MHz, CDCl.sub.3) ? (ppm): 1.39 (m, 2H, CH.sub.2CH.sub.2CH.sub.2N); 1.53 (m, 4H, CH.sub.2CH.sub.2CH.sub.2N); 1.74 (m, 2H, (O)CCH.sub.2CH.sub.2CH.sub.2N); 2.13 (s, 3H, CH.sub.3(O)C); 2.24 (t, J=7.5 Hz, 2H, (O)CCH.sub.2CH.sub.2CH.sub.2N); 2.32 (bs, 4H, CH.sub.2CH.sub.2CH.sub.2N); 2.41 (t, J=7.0 Hz, 2H, (O)CCH.sub.2CH.sub.2CH.sub.2N).
[0171] .sup.13C NMR (100 MHz, CDCl.sub.3) ? (ppm): 21.3 ((O)CCH.sub.2CH.sub.2CH.sub.2N); 24.5 (CH.sub.2CH.sub.2CH.sub.2N); 26.0 (CH.sub.2CH.sub.2CH.sub.2N); 30.1 (C(O)CH.sub.3); 41.8 ((O)CCH.sub.2CH.sub.2CH.sub.2N); 54.6 (CH.sub.2CH.sub.2CH.sub.2N); 58.6 ((O)CCH.sub.2CH.sub.2CH.sub.2N); 209.0 (C(O)).
B.3 Synthesis of 1-ethyl-4-oxopentyl-piperidinium bromide [EPipP4K]Br
[0172] 3.3 mL (40 mmol) of bromoethane are added under an inert atmosphere to a solution of 3.53 g (20.1 mmol) of 5-(piperidinyl)pentan-2-one synthesised in paragraph B.2 in 10 mL of acetonitrile. The mixture is then heated to 80? C. for 12 h. After cooling, the mixture is concentrated under vacuum. The resulting solid is dissolved in a minimum of dichloromethane and re-precipitated by the addition of ethyl acetate. The solid is then washed two times with ethyl acetate and then dried under vacuum. The compound [EPipP4K]Br, noted as 18, thus obtained is in the form of a slightly yellow solid (5.28 g, i.e. a yield of 95%).
[0173] The characterisation data of this compound are the following:
[0174] .sup.1H NMR (400 MHz, CDCl.sub.3) ? (ppm): 1.35 (t, J=7.5 Hz, CH.sub.3CH.sub.2N); 1.74 (m, 2H, CH.sub.2CH.sub.2CH.sub.2N); 1.79-1.97 (m, 6H, CH.sub.2CH.sub.2CH.sub.2N; (O)CCH.sub.2CH.sub.2CH.sub.2N); 2.12 (s, 3H, CH.sub.3(O)C); 2.72 (t, J=6.0 Hz, 2H, (O)CCH.sub.2CH.sub.2CH.sub.2N); 3.47-3.63 (m, 8H, CH.sub.2CH.sub.2CH.sub.2N; (O)CCH.sub.2CH.sub.2CH.sub.2N; CH.sub.3CH.sub.2N).
[0175] .sup.13C NMR (100 MHz, CDCl.sub.3) ? (ppm): 7.5 (CH.sub.3CH.sub.2N); 16.0; 19.8 (CH.sub.2CH.sub.2CH.sub.2N; (O)CCH.sub.2CH.sub.2CH.sub.2N); 20.8 (CH.sub.2CH.sub.2CH.sub.2N); 30.1 (C(O)CH.sub.3); 39.1 ((O)CCH.sub.2CH.sub.2CH.sub.2N); 54.2; 56.3 (CH.sub.2CH.sub.2CH.sub.2N); 58.7 (CH.sub.3CH.sub.2N); 207.3 (C(O)).
1.2 Synthesis of Ionic Liquids (Compounds LI)
[0176] The ionic liquids comprising a ketone function used in the context of the present invention are obtained from the intermediate compounds as synthesised in chapter 1.1 above, by means of exchange of the halide anion (Br.sup.?, I.sup.? or Cl.sup.?) by the anion bis-(trifluoromethanesulfonyl)imide, NTf.sub.2.sup.?.
[0177] The corresponding reaction is dependent on the pathway A or B implemented in order to obtain the Compounds I.
1.2.1 Compounds I1 to I7 Obtained According to the Pathway A
[0178] The exchange of the halide anion by the anion NTf.sub.2.sup.? is carried out according to the following reaction (1bis):
##STR00031##
[0179] The operating protocol followed for the synthesis of the Compounds LI is described in reference to the synthesis of N-ethyl-N-(4-methyl-2-oxopentyl)piperidinium bis-(trifluoromethanesulfonyl)imide, [EPipMIBK]NTf.sub.2, noted as LI1, from the [EPipMIBK]Br (Compound I1) synthesised in chapter A.2 above.
[0180] A solution of 20.0 g (69 mmol) of lithium bis-(trifluoromethanesulfonyl)imide in 20 mL of distilled water is added to a solution of 20.0 g (68 mmol) of [EPipMIBK]Br in 20 mL of distilled water. The mixture is stirred for 2 h at ambient temperature. The biphasic mixture is then separated. The organic phase is washed with water until the silver nitrate test is negative and then the ionic liquid is dried under vacuum at 80? C. for 3 h. The compound [EPipMIBK]NTf.sub.2 obtained, noted as LI1, is in the form of a viscous yellow oil (32.1 g, i.e. a yield of 95%).
[0181] The compounds LI2 to LI7 were synthesised from the compounds I2 to I7, respectively, in accordance with the operating protocol described just above.
[0182] Table 3 below brings together the data relating to the ionic liquids LI1 to LI7 thus synthesised.
TABLE-US-00003 TABLE 3 Compound Abbreviation of Yield LI Compound I the Compound LI (%) LI1 I1 [EPipMIBK]Br [EPipMIBK]NTf.sub.2 95 LI2 I2 [EPipAcP]Br [EPipAcP]NTf.sub.2 95 LI3 I3 [EPipMAcP]Br [EPipMAcP]NTf.sub.2 95 LI4 I4 [MIMMIBK]Br [MIMMIBK]NTf.sub.2 95 LI5 I5 [PyMIBK]Br [PyMIBK]NTf.sub.2 95 LI6 I6 [EPipPin]I [EPipPin]NTf.sub.2 95 LI7 I7 [MIMPin]Cl [MIMPin]NTf.sub.2 95
[0183] The semi-structural formulas and characterisation data of these compounds LI1 to LI7 are the following:
Compound LI1: N-ethyl-N-(4-methyl-2-oxopentyl)-piperidinium bis-(trifluoromethanesulfonyl)imide, [EPipMIBK]NTf.SUB.2., Having the Formula
[0184] ##STR00032##
[0185] .sup.1H NMR (400 MHz, CDCl.sub.3) ? (ppm): 0.90 (d, 3H, J=6.5 Hz, CH.sub.3); 1.23 (t, 3H, J=7.5 Hz, CH.sub.3CH.sub.2N); 1.70 (m, 2H, CH.sub.2); 1.87 (m, 4H, CH.sub.2); 2.12 (m, 1H, CH); 2.39 (d, 2H, J=7.0 Hz, C(O)CH.sub.2); 3.44 (m, 2H, CH.sub.2N); 3.62 (m, 2H, CH.sub.2N); 3.72 (q, 2H, J=7.5 Hz, CH.sub.3CH.sub.2N); 4.22 (s, 2H, NCH.sub.2C(O)).
[0186] .sup.13C NMR (100 MHz, CDCl.sub.3) ? (ppm): 7.4 (CH.sub.3CH.sub.2N); 19.5; 20.6 (CH.sub.2); 22.1 (CH.sub.3); 24.2 (CH); 49.5 (C(O)CH.sub.2); 55.0 (CH.sub.3CH.sub.2N); 60.0 (CH.sub.2N); 61.8 (NCH.sub.2C(O)); 115.1-118.2-121.4-124.6 (q, J=321 Hz, CF.sub.3); 201.6 (C(O)).
Compound LI2: N-ethyl-N-acetophenone piperidinium bis-(trifluoromethanesulfonyl)imide, [EPipAcP]NTf.SUB.2., Having the Formula
[0187] ##STR00033##
[0188] .sup.1H NMR (400 MHz, CDCl.sub.3) ? (ppm): 1.28 (t, 3H, J=7.5 Hz, CH.sub.3CH.sub.2N); 1.76 (m, 2H, CH.sub.2); 1.94 (m, 4H, CH.sub.2); 3.60 (m, 2H, CH.sub.2CH.sub.2N); 3.85 (m, 4H, J=7.5 Hz, CH.sub.3CH.sub.2N, CH.sub.2CH.sub.2N); 4.85 (s, 2H, NCH.sub.2C(O)); 7.52 (t, 2H, J=7.5 Hz, CH.sub.Ar); 7.67 (t, 1H, J=7.5 Hz, CH.sub.Ar); 8.00 (d, 2H, J=7.5 Hz, CH.sub.Ar).
[0189] .sup.13C NMR (100 MHz, CDCl.sub.3) ? (ppm): 7.7 (CH.sub.3); 19.8; 20.8 (CH.sub.2); 55.2 (CH.sub.3CH.sub.2N); 59.6 (CH.sub.2N); 60.7 (NCH.sub.2C(O)); 115.1-118.2-121.4-124.6 (q, J=321 Hz, CF.sub.3); 128.3; 129.4 (CH.sub.Ar); 133.7 (C.sub.Ar); 135.5 (CH.sub.Ar); 190.3 (C(O)).
Compound LI3: N-ethyl-N-4-methylacetophenone piperidinium bis-(trifluoromethanesulfonyl)imide, [EPipMAcP]NTf.SUB.2., Having the Formula
[0190] ##STR00034##
[0191] .sup.1H NMR (400 MHz, CDCl.sub.3) ? (ppm): 1.28 (t, 3H, J=7.5 Hz, CH.sub.3CH.sub.2N); 1.76 (m, 2H, CH.sub.2); 1.94 (m, 4H, CH.sub.2); 3.60 (m, 2H, CH.sub.2CH.sub.2N); 3.85 (m, 4H, J=7.5 Hz, CH.sub.3CH.sub.2N, CH.sub.2CH.sub.2N); 4.85 (s, 2H, NCH.sub.2C(O)); 7.52 (t, 2H, J=7.5 Hz, CH.sub.Ar); 7.67 (t, 1H, J=7.5 Hz, CH.sub.Ar); 8.00 (d, 2H, J=7.5 Hz, CH.sub.Ar).
[0192] .sup.13C NMR (100 MHz, CDCl.sub.3) ? (ppm): 7.7 (CH.sub.3); 19.9; 20.8 (CH.sub.2); 21.8 (CH.sub.3Ar); 22.0 (CH.sub.3CH.sub.2N); 51.2 (CH.sub.3CH.sub.2N); 59.5 (CH.sub.2N); 60.8 (NCH.sub.2C(O)); 115.1-118.2-121.4-124.6 (q, J=321 Hz, CF.sub.3); 128.5; 130.1 (CH.sub.Ar); 131.2 (C.sub.Ar); 147.1 (C.sub.Ar); 189.7 (C(O)).
Compound LI4: N-methyl-N-(4-methyl-2-oxopentyl)imidazolium bis-(trifluoromethanesulfonyl)imide, [MIMMIBK]NTf.SUB.2., Having the Formula
[0193] ##STR00035##
[0194] .sup.1H NMR (400 MHz, CDCl.sub.3) ? (ppm): 0.96 (d, 3H, J=6.5 Hz, CH.sub.3); 2.17 (m, 1H, CH); 2.51 (d, 2H, J=7.0 Hz, C(O)CH.sub.2); 3.96 (s, 3H, CH.sub.3N); 5.2 (s, 2H, NCH.sub.2C(O)); 7.46 (t, 1H, J=2.0 Hz, CH.sub.Ar); 7.57 (t, 1H, J=2.0 Hz, CH.sub.Ar); 8.77 (s, 1H, J=2.0 Hz, CH.sub.Ar).
[0195] .sup.13C NMR (100 MHz, CD.sub.3OD) ? (ppm): 22.8 (CH.sub.3); 25.3 (CH); 36.6 (CH.sub.3Ar); 49.1 (C(O)CH.sub.2); 58.4 (NCH.sub.2C(O)); 116.4-119.6-122.8-126.0 (q, J=321 Hz, CF.sub.3); 124.4 (CH.sub.Ar); 125.0 (CH.sub.Ar); 139.0 (CH.sub.Ar); 202.3 (C(O)).
Compound LI5: N-(4-methyl-2-oxopentyl)pyridinium bis-(trifluoromethanesulfonyl)imide, [PyMIBK]NTf.SUB.2., Having the Formula
[0196] ##STR00036##
[0197] .sup.1H NMR (400 MHz, CDCl.sub.3) ? (ppm): 1.00 (d, 3H, J=6.5 Hz, CH.sub.3); 2.20 (m, 1H, CH); 2.61 (d, 2H, J=7.0 Hz, C(O)CH.sub.2); 5.67 (s, 2H, NCH.sub.2C(O)); 8.14 (m, 2H, CH.sub.Ar); 8.66 (tt, 1H, J=8.0 Hz; J=1.5 Hz, CH.sub.Ar); 8.74 (m, 2H, CH.sub.Ar).
[0198] .sup.3C NMR (100 MHz, CD.sub.3OD) ? (ppm): 22.9 (CH.sub.3); 25.3 (CH); 49.1 (C(O)CH.sub.2); 69.6 (NCH.sub.2C(O)); 116.4-119.6-122.8-126.0 (q, J=321 Hz, CF.sub.3); 129.2 (CH.sub.Ar); 147.3 (CH.sub.Ar); 147.6 (CH.sub.Ar); 201.4 (C(O)).
Compound LI6: N-ethyl-N-pinacolone piperidinium bis-(trifluoromethanesulfonyl)imide, [EPipPin]NTf.SUB.2., Having the Formula
[0199] ##STR00037##
[0200] .sup.1H NMR (400 MHz, CDCl.sub.3) ? (ppm): 1.23 (s, 9H, CH.sub.3); 1.26 (t, 3H, J=7.5 Hz, CH.sub.3CH.sub.2N); 1.75 (m, 2H, CH.sub.2); 1.88 (m, 4H, CH.sub.2); 3.54 (m, 2H, CH.sub.2N); 3.68 (m, 2H, CH.sub.2N); 3.74 (q, 2H, J=7.5 Hz, CH.sub.3CH.sub.2N); 4.40 (s, 2H, NCH.sub.2C(O)).
[0201] .sup.13C NMR (100 MHz, CDCl.sub.3) ? (ppm): 7.6 (CH.sub.3CH.sub.2N); 19.8; 20.8 (CH.sub.2); 26.1 (CH.sub.3); 45.1 (C(O)C(CH.sub.3).sub.3); 53.6 (CH.sub.3CH.sub.2N); 59.5 (NCH.sub.2C(O)); 60.1 (CH.sub.2N); 115.1-118.2-121.5-124.7 (q, J=321 Hz, CF.sub.3); 207.6 (C(O)).
Compound LI7: N-pinacolone methylimidazolium bis-(trifluoromethanesulfonyl)imide, [MIMPin]NTf.SUB.2., Having the Formula
[0202] ##STR00038##
[0203] .sup.1H NMR (400 MHz, CDCl.sub.3) ? (ppm): 1.25 (s, 9H, CH.sub.3); 3.94 (s, 3H, CH.sub.3Ar); 5.31 (s, 2H, NCH.sub.2C(O)); 7.28 (3, 2H, CH.sub.Ar); 8.69 (S, 1H, CH.sub.Ar).
[0204] .sup.13C NMR (100 MHz, CDCl.sub.3) ? (ppm): 26.0 (CH.sub.3); 36.5 (CH.sub.3N); 43.6 ((CH.sub.3).sub.3CC(O)); 53.9 (C(O)CH.sub.2N); 115.1-118.2-121.4-124.6 (q, J=321 Hz, CF.sub.3); 122.8 (CH.sub.Ar); 124.1 (CH.sub.Ar); 137.7 (CH.sub.Ar); 206.0 (C(O)).
1.2.2 Compound I8 Obtained According to the Pathway B
[0205] The exchange of the halide anion of the Compound I8 synthesised in chapter B.3 above by the anion NTf.sub.2.sup.? is carried out according to the following reaction (2bis):
##STR00039##
[0206] The synthesis protocol followed for the synthesis of the Compound LI8 is the following: a solution of 5.5 g (20 mmol) of lithium bis-(trifluoromethanesulfonyl)imide in 10 mL of distilled water is added to a solution of 5.28 g (19.5 mmol) of [EPipP4K]Br in 10 mL of deionised water. The mixture is then stirred for 3 h. The aqueous phase is then eliminated. The product is then washed with water (3 times with 15 mL) and then dissolved in dichloromethane. The mixture is then dried over magnesium sulphate, filtered and concentrated under vacuum. The 1-ethyl-4-oxopentyl-piperidinium bis-(trifluoromethanesulfonyl)imide, or [EPipP4K]NTF.sub.2, noted as LI8, thus obtained is in the form of a yellow oil (7.6 g, i.e. a yield of 83%).
[0207] The characterisation data of this Compound LI8 are the following:
[0208] .sup.1H NMR (400 MHz, CDCl.sub.3) ? (ppm): 1.34 (t, J=7.5 Hz, CH.sub.3CH.sub.2N); 1.71 (m, 2H, CH.sub.2CH.sub.2CH.sub.2N); 1.80-1.96 (m, 6H, CH.sub.2CH.sub.2CH.sub.2N; (O)CCH.sub.2CH.sub.2CH.sub.2N); 2.15 (s, 3H, CH.sub.3(O)C); 2.64 (t, J=6.0 Hz, 2H, (O)CCH.sub.2CH.sub.2CH.sub.2N); 3.21 (m, 2H, (O)CCH.sub.2CH.sub.2CH.sub.2N); 3.25-3.37 (m, 6H, CH.sub.2CH.sub.2CH.sub.2N; CH.sub.3CH.sub.2N).
[0209] .sup.13C NMR (100 MHz, CDCl.sub.3) ? (ppm): 7.0 (CH.sub.3CH.sub.2N); 15.4; 19.5 (CH.sub.2CH.sub.2CH.sub.2N; (O)CCH.sub.2CH.sub.2CH.sub.2N); 20.9 (CH.sub.2CH.sub.2CH.sub.2N); 29.8 (C(O)CH.sub.3); 38.6 ((O)CCH.sub.2CH.sub.2CH.sub.2N); 54.7; 56.3 (CH.sub.2CH.sub.2CH.sub.2N); 59.2 (CH.sub.3CH.sub.2N); 115.1-118.3-121.5-124.7 (q, J=321 Hz, CF.sub.3); 207.3 (C(O)).
Example 2: Synthesis of an Ionic Liquid LI19 Comprising an Alcohol Function
[0210] This ionic liquid LI9 can be synthesised according to the following reaction (3bis):
##STR00040##
[0211] The corresponding operating protocol is the following: a solution of 10.3 g (36 mmol) of lithium bis-(trifluoromethanesulfonyl)imide in 20 mL of water is added to a solution of 5 g (36 mmol) of choline chloride in 20 mL of water. The mixture is stirred for 3 h at ambient temperature, then the phases are separated. The ionic liquid is washed two times with 30 mL of water and then dried under vacuum.
[0212] The characterisation data of this Compound LI9 are the following:
[0213] .sup.1H NMR (400 MHz, DMSO-d.sub.6) ? (ppm): d 5.27 (t, 1H), 3.83 (m, 2H), 3.39 (m, 2H), 3.10 (s, 9H).
Example 3: Synthesis of an Ionic Liquid LI10 Comprising a Phosphonate Function
[0214] As described above, the ionic liquids comprising a phosphonate function can be synthesised according to the following reaction (6):
##STR00041##
[0215] The ionic liquid LI10 is synthesised from ethylpiperidine, according to the following operating protocol:
3.1 Synthesis of (4-bromobutyl)-ethylpiperidinium bromide [EPipBPhos]Br
[0216] 15 mL (122 mmol) of dibromobutane are added to a solution of 9 mL (66 mmol) of ethylpiperidine in 50 mL of ethyl acetate. The mixture is then stirred at 50? C. for one night. After cooling, the solid is filtered, washed with diethyl ether (two times with 30 mL) and dried under vacuum. The (4-bromobutyl)-ethylpiperidinium bromide (14.8 g, i.e. a yield of 68%) that is in the form of a white solid is obtained.
[0217] The characterisation data of this compound are the following:
[0218] .sup.1H NMR (400 MHz, CDCl.sub.3) ? (ppm): 1.36 (t, J=7.5 Hz, 3H, CH.sub.3CH.sub.2N); 1.77-1.85 (m, 2H, CH.sub.2CH.sub.2CH.sub.2N); 1.90-2.05 (m, 4H, CH.sub.2CH.sub.2CH.sub.2N); 2.31-2.41 (m, 2H, CH.sub.2CH.sub.2CH.sub.2Br); 3.62 (t, J=6.0 Hz, 2H, CH.sub.2Br); 3.67-3.77 (m, 8H, CH.sub.2N).
[0219] .sup.13C NMR (100 MHz, CDCl.sub.3) ? (ppm): 7.3 (CH.sub.3CH.sub.2N); 20.0 (CH.sub.2CH.sub.2CH.sub.2N); 20.8 (CH.sub.2CH.sub.2CH.sub.2N); 25.0 (NCH.sub.2CH.sub.2CH.sub.2Br); 29.6 (NCH.sub.2CH.sub.2CH.sub.2Br); 54.6 (CH.sub.3CH.sub.2N); 56.2 (NCH.sub.2CH.sub.2CH.sub.2Br); 59.2 (CH.sub.2CH.sub.2CH.sub.2N).
3.2 Synthesis of (4-bromobutyl)-ethylpiperidinium bis-(trifluoromethanesulfonyl)imide
[0220] A solution of 10.8 g (38 mmol) of lithium bis-(trifluoromethanesulfonyl)imide in 10 mL of water is added to a solution of 12.3 g (37 mmol) of (4-bromobutyl)-ethylpiperidinium bromide in 30 mL of water. The mixture is stirred for 3 h at ambient temperature and then the phases are separated. The ionic liquid is washed 3 times with 30 mL of water and then dried under vacuum. The (4-bromobutyl)ethylpiperidinium bis-(trifluoromethanesulfonyl)imide (16.32 g, i.e. a yield of 83%) obtained is in the form of a colourless viscous oil.
[0221] The characterisation data of this compound are the following:
[0222] .sup.1H NMR (400 MHz, CD.sub.2Cl.sub.2) ? (ppm): 1.36 (t, J=7.5 Hz, 3H, CH.sub.3); 1.73-1.79 (m, 2H, CH.sub.2CH.sub.2CH.sub.2N); 1.89-1.96 (bs, 4H, CH.sub.2CH.sub.2CH.sub.2N); 2.22-2.31 (m, 2H, CH.sub.2CH.sub.2CH.sub.2Br); 3.30-3.34 (m, 8H, CH.sub.2N); 3.55 (t, J=6.0 Hz, 2H, CH.sub.2Br)
[0223] .sup.13C NMR (100 MHz, CD.sub.2Cl.sub.2) ? (ppm): 6.9 (CH.sub.3CH.sub.2N); 19.5 (CH.sub.2CH.sub.2CH.sub.2N); 20.8 (CH.sub.2CH.sub.2CH.sub.2N); 24.4 (NCH.sub.2CH.sub.2CH.sub.2Br); 28.7 (NCH.sub.2CH.sub.2CH.sub.2Br); 54.6 (CH.sub.3CH.sub.2N); 56.6 (NCH.sub.2CH.sub.2CH.sub.2Br); 59.2 (CH.sub.2CH.sub.2CH.sub.2N); 115.1-118.2-121.4-124.6 (q, J=321 Hz, CF.sub.3)
3.3 Synthesis of (4-(dibutoxyphosphory)butyl)-ethylpiperidinium bis-(trifluoromethanesulfonyl)imide [EPipBPhos]NTf.SUB.2., or Compound LI10 Having the Formula
[0224] ##STR00042##
[0225] A mixture of 16.32 g (31 mmol) of (4-bromobutyl)-ethylpiperidinium bis-(trifluoromethanesulfonyl)imide and of 25 mL (92 mmol) of tributylphosphite is stirred at 160? C. for 1 h. After cooling, the mixture is washed two times with ether and the compound is dried under vacuum. The (4-(dibutoxyphosphory)butyl)-ethylpiperidinium bis-(trifluoromethanesulfonyl)imide [EPipBPhos]NTf.sub.2 obtained, noted as LI10, is in the form of a colourless oil (16.9 g, i.e. a yield of 85%).
[0226] The characterisation data of this Compound LI10 are the following:
[0227] .sup.1H NMR (400 MHz, CDCl.sub.3) ? (ppm): 0.93 (t, J=7.5 Hz, 6H, CH.sub.3(CH.sub.2).sub.3O); 1.32 (t, J=7.5 Hz, 3H, CH.sub.3CH.sub.2N); 1.36-1.43 (m, 4 h, CH.sub.3CH.sub.2(CH.sub.2).sub.2O); 1.60-1.88 (m, 16H, CH.sub.2P; CH.sub.2); 3.24 (m, 2H, CH.sub.2N); 3.31-3.40 (m, 6H, CH.sub.2N); 4.0 (m, 4H, OCH.sub.2(CH.sub.2).sub.3CH.sub.3)
[0228] .sup.13C NMR (100 MHz, CDCl.sub.3) ? (ppm): 7.2 (CH.sub.3); 13.6 (CH.sub.3(CH.sub.2).sub.3O); 18.8 (CH.sub.3CH.sub.2(CH.sub.2).sub.2O); 19.7 (CH.sub.2CH.sub.2N); 20.0; 20.9; 21.6; 21.7 (CH.sub.2CH.sub.2N); 23.5-25.0 (d, J=140.0 Hz, CH.sub.2P); 32.5; 32.6 (d, J=6.5 Hz, CH.sub.3CH.sub.2CH.sub.2CH.sub.2O); 54.0; 57.9; 59.2 (CH.sub.2N); 65.6 (d, J=7.0 Hz, CH.sub.2O); 115.2-118.3-121.5-124.7 (q, J=321 Hz, CF.sub.3)
[0229] .sup.31P NMR (160 MHz, CDCl.sub.3) ? (ppm): 30.3
Extractive Properties of the Ionic Liquids
Methods of Evaluating the Extractive Properties
[0230] The extractive properties of the ionic liquids were evaluated by the measurement of the coefficients of distribution of the species in solution, by means of Inductively Coupled Plasma-Optical Emission Spectrometry or ICP-OES.
[0231] The efficiency of extraction, or of stripping, is evaluated by the determination of the percentage of extraction, or of stripping, from the coefficient of distribution, as explained below. [0232] The coefficient of distribution of a metal element M, noted as D.sub.M, between the phase consisting of the ionic liquid (noted as A2) and the aqueous phase (noted as A1) is determined by the following equation:
Operating Protocols
[0247] The acid aqueous phases A1 were prepared by dilution, in sulphuric acid, of Ta in the oxidation state V and in the form of NH.sub.4TaF.sub.6 containing 1% hydrofluoric acid in ion-exchanged water, from the company SCP Science.
[0248] The compositions of the acid aqueous phases A1, before contact, are the following, with the unit M used below and hereinafter corresponding to the abbreviation of the International System unit mol/L: [0249] [Ta]: from 1 g/L to 10 g/L, [0250] [H.sub.2SO.sub.4]: from 0M to 9M, [0251] with optional addition of niobium Nb and europium Eu, in order to approach the conditions encountered with an acid aqueous phase consisting of an acid digestion solution a concentrate of a natural ore in which Nb is present with Ta, [0252] with optional addition of niobium Nb, iron Fe, manganese Mn, nickel Ni and silver Ag, in order to approach the conditions encountered with an acid aqueous phase consisting of an acid digestion solution of a concentrate of a phosphate ore that contains mainly Ta, Nb, Fe and Mn, or of an urban ore from capacitors from W3E that contain mainly Ta, Mn, Ni and Ag.
[0253] The aqueous phase A3 used for the strippings consists of water.
[0254] The extractions are carried out by bringing the acid aqueous phase A1 into contact with the ionic liquid A2 considered in a volume ratio between the acid aqueous phase and the ionic liquid V.sub.A1/V.sub.A2 ranging from 1 to 16.
[0255] The acid aqueous phase A1 and the ionic liquid A2 are put in contact for 1 h and at a temperature between 20? C. and 25? C. and then centrifuged for 5 min at 4000 rpm at 20? C. and separated.
[0256] The strippings are carried out in the same time of contact, temperature and centrifugation conditions, except for the volume ratio between the aqueous phase A3 and the ionic liquid V.sub.A3/V.sub.A2 that is 1 or 2.
[0257] The dosage of the metal elements present in the aqueous phases is carried out by ICP-OES analysis.
Experimental Results
Example 4: Extraction by Ionic Liquids Comprising a Ketone Function
[0258] 4.1 In order to determine the effect of the molar concentration of sulphuric acid of the aqueous phase A1 on the extraction performance, a first series of extractions was carried out by bringing the following phases A1 and A2 into contact in equal volumes: [0259] Aqueous phase A1: [Ta]=1 g/L in variable concentrations of sulphuric acid ([H.sub.2SO.sub.4]=from 0M to 9M) [0260] Phase A2: Ionic liquid LI1: [EPipMIBK]NTf.sub.2
[0261] The calculated values for the coefficients of distribution of the tantalum D.sub.Ta and the percentages of extraction E (%) and of stripping D?sex (%) are reported in table 4.1.
TABLE-US-00004 TABLE 4.1 [H.sub.2SO.sub.4] (in M) D.sub.Ta E (%) D?sex (%) 0 0.1 9.1 0.01 0.1 9.1 0.1 0.15 13.0 1 0.3 23.1 3 10.3 91.1 85 6 43.5 97.7 100 9 40.2 97.6 100
[0262] Also in reference to
[0263] 4.2 In order to determine the effect of the molar concentration of sulphuric acid of the aqueous phase A1 on the selectivity of the extraction, a second series of extractions was carried out by bringing the following phases A1 and A2 into contact in equal volumes: [0264] Aqueous phase A1: [Ta]=[Nb]=1 g/L, [Eu]=1.5 g/L in variable concentrations of sulphuric acid ([H.sub.2SO.sub.4]=from 3M to 9M) [0265] Phase A2: Ionic liquid LI1: [EPipMIBK]NTf.sub.2
[0266] The percentages of extraction E.sub.M (%) of each of the metals Ta, Nb and Eu initially present in the aqueous phase A1 are illustrated in
[0267] The percentages of extraction E (%) and of stripping D?sex (%) of the tantalum, as well as the values calculated for the selectivity of the Ta with respect to Nb and Eu, noted as S.sub.Ta/Nb and S.sub.Ta/Eu, respectively, are reported in table 4.2 below:
TABLE-US-00005 TABLE 4.2 [H.sub.2SO.sub.4] (in M) E (%) D?sex (%) S.sub.Ta/Nb S.sub.Ta/Eu 3 91.1 95 130 375 6 97.7 100 237 495 9 97.6 100 210 515
[0268] The results of table 4.2 show that the ionic liquid LI1 is a very selective extractant of tantalum, regardless of the molar concentration of sulphuric acid of the aqueous phase A1, and that the tantalum can be completely stripped.
[0269] 4.3 In order to determine the effect of the nitrogen portion of the cation of the ionic liquid of the phase A2 on the extraction performance, a third series of extractions was carried out by bringing the following phases A1 and A2 into contact in equal volumes: [0270] Aqueous phase A1: [Ta]=7 g/L, in sulphuric acid ([H.sub.2SO.sub.4]=6M) [0271] Phase A2: Ionic liquid: LI1, LI4 and LI5
[0272] The calculated values for the coefficients of distribution of the tantalum D.sub.Ta, as well as the percentages of extraction E (%) and of stripping D?sex (%), are reported in table 4.3 below:
TABLE-US-00006 TABLE 4.3 E D?sex Phase A2 D.sub.Ta (%) (%) LI1 [EPip MIBK] NTf.sub.2
[0273] It is observed that the extraction is particularly efficient regardless of the ionic liquid chosen out of LI1, LI4 and LI5, the extraction percentages ranging between 95.4% and 97.7%.
[0274] 4.4 In order to determine the effect of the ketone portion of the cation of the ionic liquid of the phase A2 on the extraction performance, a fourth series of extractions was carried out by bringing the following phases A1 and A2 into contact in equal volumes: [0275] Aqueous phase A1: [Ta]=1 g/L or [Ta]=7 g/L, in sulphuric acid ([H.sub.2SO.sub.4]=6M) [0276] Phase A2: Ionic liquid: LI1, LI2, LI3, LI5, LI6 or LI7
[0277] The calculated values for the coefficients of distribution of the tantalum D.sub.Ta, as well as the percentages of extraction E (%) and of stripping D?sex (%), for each mass concentration of Ta, are reported in table 4.4 below:
TABLE-US-00007 TABLE 4.4 [Ta] = 1 g/L [Ta] = 7 g/L E D?sex E D?sex Phase A2 DTa (%) (%) DTa (%) (%) LI1 [EPipMIBK] NTf.sub.2
[0278] As is clear from table 4.4, when the ketone function of the ionic liquid comprises an aliphatic chain (here, isobutyl or tertio-butyl), very good extraction results are obtained, with the extraction percentages ranging between 95.2% and 97.7% (ionic liquids LI1, LI6, LI7 and LI8). The ionic liquid LI1, which has a methyl isobutyl ketone (MIBK) group, has slightly better performance than the ionic liquid LI6 that has a tertbutyl group.
[0279] When the ketone function of the ionic liquid comprises an aromatic group (LI2 and LI3), the performance of the extraction falls because of the high viscosity of the corresponding ionic liquids, said viscosity forming an obstacle to the extraction and stripping.
[0280] Table 4.4 also shows the fact that the extraction decreases substantially when the concentration of Ta increases.
[0281] The ionic liquid LI1 [EPipMIBK]NTf.sub.2 is the extractant with the best performance.
[0282] 4.5 In order to evaluate the ability of the ionic liquid L1 [EPipMIBK]NTf.sub.2 to be reused, recycling tests were carried out by placing the following initial phases A1 and A2 in contact in equal volumes: [0283] Aqueous phase A1: [Ta]=7 g/L, in sulphuric acid ([H.sub.2SO.sub.4]=6M) [0284] Phase A2: Ionic liquid: LI1
[0285] After a first cycle of extraction/stripping (cycle 1), the ionic liquid LI1 as obtained after the stripping is used for a second extraction/stripping cycle (cycle 2) followed by a third (cycle 3). The results of these recycling tests are reported in table 4.5 below:
TABLE-US-00008 TABLE 4.5 Cycle D.sub.Ta E (%) D?sex (%) 1 33.4 97 94 2 27.2 96.4 93 3 30.8 96.9 96
[0286] Table 4.5 shows that the ionic liquid LI1 was recycled 3 times without losing efficiency.
[0287] 4.6 In order to determine the performance of extraction of the Ta from an aqueous phase A1 comprising a plurality of metal elements, a fourth series of extractions was carried out by bringing the following phases A1 and A2 into contact in equal volumes: [0288] Aqueous phase A1: [Ta]=[Nb]=[Fe]=[Ni]=[Mn]=[Ag]=2 g/L, in variable concentrations of sulphuric acid ([H.sub.2SO.sub.4]=from 0.1M to 9M) [0289] Phase A2: Ionic liquid: LI1
[0290] In reference to
[0291] In reference to
[0292] In reference to
[0293] In reference to
Example 5: Extraction by Non-Functionalised Ionic Liquids
[0294] 5.1 A first series of extractions was carried out by bringing the following phases A1 and A2 into contact in equal volumes: [0295] Aqueous phase A1: [Ta]=7 g/L, in sulphuric acid ([H.sub.2SO.sub.4]=6M) [0296] Phase A2: Ionic liquid: LI11 or LI12, as specified in table 5 below
[0297] The calculated values for the coefficients of distribution of the tantalum D.sub.Ta, as well as the percentages of extraction E (%) and of stripping D?sex (%), after a first and then a second cycle of extraction/stripping, are reported in table 5 below:
TABLE-US-00009 TABLE 5 Cycle 1 Cycle 2 E D?sex E D?sex Phase A2 DTa (%) (%) DTa (%) (%) LI11 [EBPip]NTf.sub.2
[0298] These non-functionalised ionic liquids LI11 and LI12 have performance that is as good as that of their equivalents functionalised by a ketone group (see in particular LI8, but also LI1, LI6 or even LI4, LI7), with a slight reduction in the performance of stripping of the Ta.
[0299] The tendency towards better extraction of the Ta with the piperidine core (LI11) is again observed.
[0300] 5.2 In order to determine the performance of extraction of the Ta from an aqueous phase A1 comprising a plurality of metal elements, a second series of extractions was carried out by bringing the following phases A1 and A2 into contact in equal volumes: [0301] Aqueous phase A1: [Ta]=[Nb]=[Fe]=[Ni]=[Mn]=[Ag]=2 g/L, in variable concentrations of sulphuric acid ([H.sub.2SO.sub.4]=from 0.1M to 9M) [0302] Phase A2: Ionic liquid: LI11
[0303] In reference to
[0304] In reference to
[0305] This selectivity of the extraction of Ta with respect to the other metals by means of the ionic liquid LI11 is observed regardless of the molar concentration of sulphuric acid, as already observed with the ionic liquid L1 ([EPipMIBK]NTf.sub.2).
[0306] 5.3 In order to evaluate the ability of the ionic liquid LI11 [EBPip]NTf.sub.2 to be able to be reused, recycling tests were carried out by bringing the following initial phases A1 and A2 into contact in equal volumes: [0307] Aqueous phase A1: [Ta]=[Nb]=[Fe]=[Ni]=[Mn]=[Ag]=2 g/L, in variable concentrations of sulphuric acid ([H.sub.2SO.sub.4]=from 0.1M to 9M) [0308] Phase A2: Ionic liquid: LI11
[0309] After a first cycle of extraction/stripping (cycle 1), the ionic liquid LI11 as obtained after the stripping is used for a second cycle of extraction/stripping (cycle 2) followed by a third (cycle 3).
[0310] The results of these recycling tests are illustrated in the appended
Example 6: Extraction by an Ionic Liquid Comprising a Phosphonate Function
[0311] 6.1 A first series of extractions was carried out by bringing the following phases A1 and A2 into contact in equal volumes: [0312] Aqueous phase A1: [Ta]=7 g/L, in sulphuric acid ([H.sub.2SO.sub.4]=6M) [0313] Phase A2: Ionic liquid: LI10, [EPipBPhos]NTf.sub.2
[0314] The calculated values for the coefficients of distribution of the tantalum D.sub.Ta, as well as the percentages of extraction E (%) and of stripping D?sex (%), after a first cycle of extraction/stripping (cycle 1) and then a second (cycle 2), are reported in table 6.1 below:
TABLE-US-00010 TABLE 6.1 Cycle 1 Cycle 2 E D?sex E D?sex Phase A2 D.sub.Ta (%) (%) D.sub.Ta (%) (%) LI10 [EPipBPhos] NTf.sub.2
[0315] The values in this table 6.1 show the particularly high-performing properties of this ionic liquid LI10 comprising a phosphonate function, since almost the entirety of the Ta can be extracted from the aqueous phase A1, the percentages of extraction being 99.4% and 99.6%. The percentages of stripping are also high (72% and 89%).
[0316] 6.2 A second series of extractions was carried out by bringing the following phases A1 and A2 into contact, in volume ratios that vary between the phase A1 and the phase A2, as indicated in table 6.2 below: [0317] Aqueous phase A1: [Ta]=7 g/L, in sulphuric acid ([H.sub.2SO.sub.4]=6M) [0318] Phase A2: Ionic liquid: LI10, [EPipBPhos]NTf.sub.2
[0319] The calculated values for the coefficients of distribution of the tantalum D.sub.Ta, as well as the percentages of extraction E (%), are reported in table 6.2 below:
TABLE-US-00011 TABLE 6.2 V.sub.A1/V.sub.A2 D.sub.Ta E (%) 1 150 99.3 2 266 99.3 4 270 98.5 8 150 94.9 16 77 82.8
[0320] The results of table 6.2 show that this ionic liquid LI10 has an excellent ability to extract the tantalum. Thus, even in the case in which the volume of the aqueous phase A1 is sixteen times greater than that of the phase A2, LI10 allows up to 82.8% of Ta to be extracted, the aqueous phase A1 initially comprising 7 g/L of Ta.
[0321] 6.3 In order to determine the performance of extraction of the Ta from an aqueous phase A1 comprising a plurality of metal elements, a third series of extractions was carried out by bringing the following phases A1 and A2 into contact in equal volumes: [0322] Aqueous phase A1: [Ta]=[Nb]=[Fe]=[Ni]=[Mn]=[Ag]=2 g/L, in variable concentrations of sulphuric acid ([H.sub.2SO.sub.4]=from 0.1M to 9M) [0323] Phase A2: Ionic liquid: LI10, [EPipBPhos]NTf.sub.2
[0324] In reference to
[0325] In reference to
[0326] 6.4 In order to evaluate the ability of the ionic liquid LI10 [EPipBPhos]NTf.sub.2 to be reused, recycling tests were carried out by bringing the following initial phases A1 and A2 into contact in equal volumes: [0327] Aqueous phase A1: [Ta]=[Nb]=[Fe]=[Ni]=[Mn]=[Ag]=2 g/L, in variable concentrations of sulphuric acid ([H.sub.2SO.sub.4]=from 0.1M to 9M) [0328] Phase A2: Ionic liquid: LI10, [EPipBPhos]NTf.sub.2
[0329] After a first cycle of extraction/stripping (cycle 1), the ionic liquid LI10 as obtained after the stripping is used for a second cycle of extraction/stripping (cycle 2) followed by a third (cycle 3).
[0330] The results of these recycling tests are illustrated in the appended
Example 7: Extraction by a Mixture of Two Ionic Liquids
[0331] A series of extractions was carried out by bringing the following phases A1 and A2 into contact in equal volumes: [0332] Aqueous phase A1: [Ta]=7 g/L, in sulphuric acid ([H.sub.2SO.sub.4]=6M) [0333] Phase A2: Ionic liquids: LI1+LI11, [EPipMIBK]NTf.sub.2+[EBPip]NTf.sub.2, in variable proportions specified in table 7 below
[0334] The calculated values for the coefficients of distribution of the tantalum D.sub.Ta, as well as the percentages of extraction E (%) and of stripping D?sex (%), are reported in table 7 below:
TABLE-US-00012 TABLE 7 Proportion of LI1 in LI11 (%) D.sub.Ta E (%) D?sex (%) 1 38.3 97.5 75 2 40.2 97.6 70 10 40.9 97.6 68 20 37 97.4 75 50 36 97.3 75
[0335] According to the results of table 7, it is observed that regardless of the ratio of [EPipMIBK]NTf.sub.2 in [EBPip]NTf.sub.2, the percentages of extraction are substantially the same.
Example 8: Electrodeposition of the Tantalum
[0336] Three electrodeposition trials were carried out using the electrolytic solution formed by the phase A2 as obtained from the extraction described in paragraph 5.1 above and comprising the tantalum extracted in the ionic liquid LI11 [EBPip]NTf.sub.2.
[0337] A cathode, a reference electrode and, as a working electrode, successively, a substrate made of aluminium, a substrate made of titanium and a substrate made of carbon were positioned in this electrolytic solution.
[0338] The reference electrode consists of a silver wire submerged in a solution of AgCF.sub.3SO.sub.3 (at 10 mmol/L) in the ionic liquid 1-butyl-3-methylimidazolium trifluoromethanesulfonate (BMICF.sub.3SO.sub.3).
[0339] Then, a difference in potential that ranges between ?1.4V and ?2.1V, according to the substrate tested, was applied between the cathode and the reference electrode.
[0340] In the particular case of the substrate made of aluminium, a difference in potential of ?1.5V with respect to the reference electrode was applied, the electrolytic solution being maintained at a temperature of 110? C. The metal deposit obtained at the cathode is then rinsed with isopropanol and then water in order to be analysed.
[0341] This deposit was the subject of an image via a scanning electron microscope (SEM) as well as of an analysis with an energy dispersive X-ray spectrometry probe (abbreviated EDX) in order to determine its chemical composition.
[0342] The results of this SEM image and EDX analysis, presented in
[0343] A deposit of tantalum in its metallic form is also observed for the trials carried out with each of the other substrates made of titanium and of carbon.